Assessment of Sea Sickness in Naval Personnel: Incidence and Management.
Motion sickness assessment questionnaire
behavioral strategy
medications
sensory conflict
Journal
Indian journal of occupational and environmental medicine
ISSN: 0973-2284
Titre abrégé: Indian J Occup Environ Med
Pays: India
ID NLM: 9815775
Informations de publication
Date de publication:
Historique:
received:
13
04
2020
accepted:
05
09
2020
entrez:
23
8
2021
pubmed:
24
8
2021
medline:
24
8
2021
Statut:
ppublish
Résumé
Strategic, operational and tactical superiority of Navy hinges on extremely efficient warships which in turn depend on professionally competent sailors ready to undertake tasks to deliver timely, structured and metered response. Ships and their potentialities are tools to achieve the required strategic advantage which is dependent on the proficiency of sailors. Sailors who are fit ashore may be debilitated on board because of sea sickness. To study the incidence and severity of sea sickness among 500 naval personnel from various ships. Setting and design: An observational study conducted from May 2019 to March 2020 among 500 naval personnel from various ships of the fleet. Motion Sickness Assessment Questionnaire (MSAQ) was used to collect data from personnel of different departments working in different part of ship aged between 20 to 50 years. The majority suffered mild symptoms (78.78%) and did not require any medication. Their symptoms were selflimiting and settled on rest within 24 hours. Moderately severe symptoms were observed among 19.31 % personnel and had to be administered medication and rest for 24 hours. Only 1.91% had severe symptoms and had to be excused from duties along with medication and rest. Sea sickness is unpleasant and has an adverse effect on employability of the sailors. It is mild and self limiting in majority of the personnel not requiring active intervention. Some personnel may require desensitisation along with pharmacotherapy.
Sections du résumé
BACKGROUND
BACKGROUND
Strategic, operational and tactical superiority of Navy hinges on extremely efficient warships which in turn depend on professionally competent sailors ready to undertake tasks to deliver timely, structured and metered response. Ships and their potentialities are tools to achieve the required strategic advantage which is dependent on the proficiency of sailors. Sailors who are fit ashore may be debilitated on board because of sea sickness.
AIMS
OBJECTIVE
To study the incidence and severity of sea sickness among 500 naval personnel from various ships. Setting and design: An observational study conducted from May 2019 to March 2020 among 500 naval personnel from various ships of the fleet.
MATERIALS AND METHODS
METHODS
Motion Sickness Assessment Questionnaire (MSAQ) was used to collect data from personnel of different departments working in different part of ship aged between 20 to 50 years.
RESULTS
RESULTS
The majority suffered mild symptoms (78.78%) and did not require any medication. Their symptoms were selflimiting and settled on rest within 24 hours. Moderately severe symptoms were observed among 19.31 % personnel and had to be administered medication and rest for 24 hours. Only 1.91% had severe symptoms and had to be excused from duties along with medication and rest.
CONCLUSION
CONCLUSIONS
Sea sickness is unpleasant and has an adverse effect on employability of the sailors. It is mild and self limiting in majority of the personnel not requiring active intervention. Some personnel may require desensitisation along with pharmacotherapy.
Identifiants
pubmed: 34421250
doi: 10.4103/ijoem.IJOEM_94_20
pii: IJOEM-25-119
pmc: PMC8341412
doi:
Types de publication
Journal Article
Langues
eng
Pagination
119-124Informations de copyright
Copyright: © 2021 Indian Journal of Occupational and Environmental Medicine.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Drugs Context. 2019 Dec 13;8:
pubmed: 32158479
Appl Ergon. 2014 May;45(3):521-7
pubmed: 23957932
Clin Neurophysiol. 2013 Dec;124(12):2445-9
pubmed: 23800706
Aviat Space Environ Med. 1994 Jun;65(6):527-30
pubmed: 8074626
Int Tinnitus J. 2004;10(2):132-6
pubmed: 15732510
Aviat Space Environ Med. 1994 Oct;65(10 Pt 2):C1-2
pubmed: 7811217
Exp Brain Res. 2014 Aug;232(8):2493-510
pubmed: 24961738
CNS Neurosci Ther. 2016 Jan;22(1):15-24
pubmed: 26452639
J Vestib Res. 2014;24(4):281-8
pubmed: 25095772
J R Soc Med. 1978 Nov;71(11):819-29
pubmed: 731645
Pharmacology. 2013;91(3-4):229-41
pubmed: 23615033
Aviat Space Environ Med. 1985 Dec;56(12):1144-51
pubmed: 4084168
J Altern Complement Med. 2012 May;18(5):494-500
pubmed: 22537562
BMC Complement Altern Med. 2013 Apr 15;13:84
pubmed: 23587135
Curr Opin Neurol. 2015 Feb;28(1):83-8
pubmed: 25502048
Am Fam Physician. 2014 Jul 1;90(1):41-6
pubmed: 25077501
Brain Res Bull. 1998 Nov 15;47(5):395-406
pubmed: 10052567
Dtsch Arztebl Int. 2018 Oct 12;115(41):687-696
pubmed: 30406755
Aviat Space Environ Med. 1988 May;59(5):399-406
pubmed: 3390095
Front Neurol. 2016 Feb 15;7:14
pubmed: 26913019
Am Fam Physician. 2007 Jun 1;75(11):1689-91
pubmed: 17575660
Exp Brain Res. 2015 May;233(5):1353-64
pubmed: 25633319